A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is now a well-recognized and potentially severe complication of HSCT that carries a …
TMA) is now a well-recognized and potentially severe complication of HSCT that carries a …
New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is an understudied complication of HSCT that significantly affects transplant-related …
TMA) is an understudied complication of HSCT that significantly affects transplant-related …
[HTML][HTML] Pulmonary hypertension after hematopoietic stem cell transplantation
Pulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell
transplantation (HSCT). Given its nonspecific clinical presentation, it is likely that this clinical …
transplantation (HSCT). Given its nonspecific clinical presentation, it is likely that this clinical …
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
SR Goldsmith, MB Abid, JJ Auletta… - Blood, The Journal …, 2021 - ashpublications.org
Prior studies suggest increased cytomegalovirus (CMV) infection after haploidentical donor
transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft …
transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft …
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab
Overactivated complement is a high-risk feature in hematopoietic stem cell transplant
(HSCT) recipients with transplant-associated thrombotic microangiopathy (TA-TMA), and …
(HSCT) recipients with transplant-associated thrombotic microangiopathy (TA-TMA), and …
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy
S Jodele, K Zhang, F Zou, B Laskin… - Blood, The Journal …, 2016 - ashpublications.org
Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after
hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and …
hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and …
[HTML][HTML] Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell …
S Jodele, T Fukuda, K Mizuno, AA Vinks… - Biology of blood and …, 2016 - Elsevier
Thrombotic microangiopathy (TMA) after hematopoietic stem cell transplantation (HSCT)
associated with terminal complement activation, as measured by elevated plasma terminal …
associated with terminal complement activation, as measured by elevated plasma terminal …
[HTML][HTML] Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant
Human studies have shown loss of diversity of the gut microbiome following hematopoietic
stem cell transplantation (HSCT) in association with significant gut injury caused by the …
stem cell transplantation (HSCT) in association with significant gut injury caused by the …
[HTML][HTML] Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients
P Khandelwal, A Teusink-Cross, SM Davies… - Biology of Blood and …, 2017 - Elsevier
We describe our retrospective clinical experience with ruxolitinib for steroid-refractory acute
graft-versus-host disease (GVHD) in pediatric allogeneic hematopoietic stem cell transplant …
graft-versus-host disease (GVHD) in pediatric allogeneic hematopoietic stem cell transplant …
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis
Background Endothelial dysfunction links thrombotic microangiopathy to steroid-refractory
graft-versus-host disease (GVHD) after allogeneic stem-cell transplantation. We aimed to …
graft-versus-host disease (GVHD) after allogeneic stem-cell transplantation. We aimed to …